NSE: JBCHEPHARM Revenue

J. B. Chemicals & Pharmaceuticals had revenue of 10.01B INR in the quarter ending September 30, 2024, with 13.48% growth. This brings the company's revenue in the last twelve months to 37.11B, up 11.35% year-over-year. In the fiscal year ending March 31, 2024, J. B. Chemicals & Pharmaceuticals had annual revenue of 34.84B with 10.63% growth.

Revenue (ttm)

37.11B

Revenue Growth

+11.35%

P/S Ratio

n/a

Revenue / Employee

6.99M

Employees

5,311

Market Cap

290.21B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	34.84B	3.35B	10.63%
Mar 31, 2023	31.49B	7.25B	29.91%
Mar 31, 2022	24.24B	3.82B	18.69%
Mar 31, 2021	20.43B	2.68B	15.09%
Mar 31, 2020	17.75B	1.32B	8.00%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

J. B. Chemicals & Pharmaceuticals News

7 weeks ago - KKR Is Said to Consider Selling $750 Million Stake in JB Pharma - BNN Bloomberg
2 months ago - Stocks to Buy This Diwali: Kotak Securities sees JB Chemicals & Pharma reaching ₹2,255, with a 19.2% upside - Business Upturn
2 months ago - Pharma Stocks Update: Natco Pharma gains 2.99%, Glenmark rises 0.07%, Granules falls 3.83% - Business Upturn
2 months ago - Pharma Stocks Update: Granules up 3.56%, Ajanta Pharma gains 2.24% while JB Chemicals drops 2.82%, Mankind Pharma down 1.40% in mixed pharma stock performance - Business Upturn
3 months ago - JB Chemicals faces valuation dispute over KKR’s 54% equity stake, potential M&A deal withdrawal looms; stock falls 4.28% - Business Upturn

More News